(Q48242157)

9 February 2018

title

Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins (English)

1 reference

9 February 2018

Erratum to: Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins

1 reference

corrigendum / erratum

0 references

author

Alejandro Speck-Planche

series ordinal

1

1 reference

9 February 2018

author name string

M Natália D S Cordeiro

series ordinal

2

1 reference

9 February 2018

publication date

13 February 2017

1 reference

9 February 2018

published in

Molecular Diversity

1 reference

9 February 2018

volume

21

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

511-523

1 reference

9 February 2018

Evaluation of chemotherapeutics in a three-dimensional breast cancer model

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Breast Cancer: Epidemiology and Etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Breast cancer statistics, 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

ChEMBL: a large-scale bioactivity database for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Abelson tyrosine-protein kinase 1 as principal target for drug discovery against leukemias. Role of the current computer-aided drug design methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Vanilloid derivatives as tyrosinase inhibitors driven by virtual screening-based QSAR models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Bond-based 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Model for high-throughput screening of drug immunotoxicity--study of the anti-microbial G1 over peritoneal macrophages using flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

First Multitarget Chemo-Bioinformatic Model To Enable the Discovery of Antibacterial Peptides against Multiple Gram-Positive Pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Enabling virtual screening of potent and safer antimicrobial agents against noma: mtk-QSBER model for simultaneous prediction of antibacterial activities and ADMET properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Chemoinformatics for medicinal chemistry: in silico model to enable the discovery of potent and safer anti-cocci agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Multi-Target QSAR Approaches for Modeling Protein Inhibitors. Simultaneous Prediction of Activities Against Biomacromolecules Present in Gram-Negative Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Investigation of molecular alterations of AKT-3 in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

The latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

PARP inhibitor treatment in ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Role of Src expression and activation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

The process of structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Non-stochastic quadratic fingerprints and LDA-based QSAR models in hit and lead generation through virtual screening: theoretical and experimental assessment of a promising method for the discovery of new antimalarial compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Prediction of tyrosinase inhibition activity using atom-based bilinear indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Atom- and bond-based 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

In silico fasciolicide activity of three experimental compounds in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Molecular properties that influence the oral bioavailability of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Tomocomd-Cardd, a novel approach for computer-aided ? rational? drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: a promising approach for modeling of antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

On the Basis of Invariants of Labeled Molecular Graphs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-017-9731-1

Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28194627

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28194627

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28194627

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11030-017-9731-1

1 reference

9 February 2018

1 reference

9 February 2018